Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Benfield

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Pharmacoeconomics|July 6, 1996
Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infectionsJ A Balfour, P Benfield
Drugs|February 1, 1995
Venlafaxine. A review of its pharmacology and therapeutic potential in depressionS M Holliday, P Benfield
Drugs & Aging|March 1, 1997
DonepezilH M Bryson, P Benfield
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 1997
[Not Available]J A Balfour, P Benfield
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Interferon-beta-1a: A Review of its Pharmacological Properties and Therapeutic Potential in Multiple SclerosisS M Holliday, P Benfield
Drugs|October 1, 1989
Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disordersP A Todd, P Benfield
Drugs|April 1, 1987
Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP Benfield, E M Sorkin
Drugs|January 1, 1994
Gallopamil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart diseaseR N Brogden, P Benfield
Drugs|July 1, 1997
NelfinavirC M Perry, P Benfield
Drugs & Aging|March 1, 1994
Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disordersC R Lee, P Benfield
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Pharmacoeconomics|July 6, 1996
Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infectionsJ A Balfour, P Benfield
Drugs|February 1, 1995
Venlafaxine. A review of its pharmacology and therapeutic potential in depressionS M Holliday, P Benfield
Drugs & Aging|March 1, 1997
DonepezilH M Bryson, P Benfield
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 1997
[Not Available]J A Balfour, P Benfield
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Interferon-beta-1a: A Review of its Pharmacological Properties and Therapeutic Potential in Multiple SclerosisS M Holliday, P Benfield
Drugs|October 1, 1989
Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disordersP A Todd, P Benfield
Drugs|April 1, 1987
Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacyP Benfield, E M Sorkin
Drugs|January 1, 1994
Gallopamil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in ischaemic heart diseaseR N Brogden, P Benfield
Drugs|July 1, 1997
NelfinavirC M Perry, P Benfield
Drugs & Aging|March 1, 1994
Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disordersC R Lee, P Benfield
Pageof 9